Clinical Trial

A Study to Test How Well Multiple Doses of BI 3810477 Are Tolerated by Healthy Adults

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The main objectives of this trial are to investigate safety, tolerability, and pharmacokinetics of BI 3810477 in healthy male and female trial participants when given as multiple rising doses.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-05-15; most recent amendment 2026-03-17.
Status change: Active, Not Recruiting → Completed 2026-03-17
Status change: Recruiting → Active, Not Recruiting 2025-12-18
Status change: Not Yet Recruiting → Recruiting 2025-06-18
Trial Details
NCT Number NCT06984926
Lead Sponsor Boehringer Ingelheim
Conditions Healthy
Enrollment 47 participants
Start Date 2025-06-06
Primary Completion 2026-03-09 (estimated)
Study Completion 2026-03-09 (estimated)
Updated on ClinicalTrials.gov 2026-03-19